All drugs decrease the moality in hea failure except:
Digoxin is used in acute CHF as well as maintenance therapy but do not retard cardiac remodelling or prolong survival in CHF patients Drugs that decrease the cardiac remodeling in a patient with CHF decrease the moality. They are: Beta blockers (metoprolol, bisoprolol) ACE inhibitors (enalapril) ARB (telmisaan) Aldosterone antagonist (spironolactone) Note Telmisaan is an ARB which has PPAR gamma agonist activity
Metoprolol
Enalapril
Telmisaan
Digoxin
Hematology and CVS